NCT03021265View on ClinicalTrials.gov

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

CompletedOBSERVATIONAL
Enrollment

676

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

April 11, 2019

Study Completion Date

April 11, 2019

Conditions
Hypertension
Interventions
DRUG

T80/A5/H12.5 FDC

Drug

Trial Locations (1)

4570047

Nippon Boehringer Ingelheim Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY